Laparoscopic resection of adrenal and extra-adrenal pheochromocytoma.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMID 23469777)

Published in J Endourol on June 06, 2013

Authors

Tetsuo Nozaki1, Hiroaki Iida, Akihiro Morii, Yasuyoshi Fujiuchi, Akiou Okumura, Hideki Fuse

Author Affiliations

1: Department of Urology, Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama, Toyama, Japan. nozaki0921@yahoo.co.jp

Articles by these authors

Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer. Cancer Sci (2008) 1.67

Ultrasound mediated intravesical transfection enhanced by treatment with lidocaine or heat. J Urol (2004) 1.49

Serum pro-gastrin-releasing peptide (31-98) in benign prostatic hyperplasia and prostatic carcinoma. Urology (2002) 1.40

Neuroendocrine differentiation in the progression of prostate cancer. Int J Urol (2009) 1.21

Evaluation of the safety and feasibility of resuscitative endovascular balloon occlusion of the aorta. J Trauma Acute Care Surg (2015) 1.16

Involvement of heat-shock protein 90 in the interleukin-6-mediated signaling pathway through STAT3. Biochem Biophys Res Commun (2003) 1.15

Serum active hepatocyte growth factor (AHGF) in benign prostatic disease and prostate cancer. Prostate (2009) 0.94

Laparoscopic resection of retrocaval paraganglioma. J Laparoendosc Adv Surg Tech A (2010) 0.91

Enhancement of ultrasound-mediated gene transfection by membrane modification. J Gene Med (2003) 0.91

Androgen receptor negatively influences the expression of chemokine receptors (CXCR4, CCR1) and ligand-mediated migration in prostate cancer DU-145. Oncol Rep (2006) 0.89

Tissue factor expression and prognosis in patients with metastatic prostate cancer. Urology (2003) 0.88

Effect of hepatocyte growth factor on invasion of prostate cancer cell lines. Oncol Rep (2003) 0.88

Oral analgesia by non-steroidal anti-inflammatory drug zaltoprofen to manage cystoscopy-related pain: a prospective study. Int J Urol (2009) 0.87

Evaluation of the sperm motility analyzer system (SMAS) for the assessment of sperm quality in infertile men. Syst Biol Reprod Med (2010) 0.87

Ablation of the scaffold protein JLP causes reduced fertility in male mice. Transgenic Res (2008) 0.86

Urachal signet ring cell carcinoma. Int J Urol (2007) 0.86

Role of resuscitative emergency field thoracotomy in the Japanese helicopter emergency medical service system. Resuscitation (2009) 0.85

Serum hepatocyte growth factor activator (HGFA) in benign prostatic hyperplasia and prostate cancer. Eur Urol (2005) 0.85

Telomerase activity is correlated with lower grade and lower stage bladder carcinomas. Int J Urol (2004) 0.85

Changes in male reproductive function after high altitude mountaineering. High Alt Med Biol (2003) 0.84

Effects of microbubbles on ultrasound-mediated gene transfer in human prostate cancer PC3 cells: comparison among Levovist, YM454, and MRX-815H. Cancer Lett (2008) 0.84

Application of a new technique, spiral tissue microarrays constructed using needle biopsy specimens, to prostate cancer research. Int J Oncol (2013) 0.83

Laparoendoscopic single-site surgery for partial nephrectomy without ischemia using a microwave tissue coagulator. Surg Innov (2012) 0.83

Primary adenocarcinoma of the appendix invading the urinary bladder. Int Urol Nephrol (2006) 0.83

Efficacy of DynaCT for surgical navigation during complex laparoscopic surgery: an initial experience. Surg Endosc (2012) 0.82

Molecular interactions between STAT3 and protein inhibitor of activated STAT3, and androgen receptor. Biochem Biophys Res Commun (2003) 0.82

PACAP-mediated sperm-cumulus cell interaction promotes fertilization. Reproduction (2010) 0.82

Clinical significance of expression of urokinase-type plasminogen activator in patients with prostate cancer. Anticancer Res (2003) 0.81

A prospective, randomized, controlled, multicenter study of naftopidil for treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia: 75 mg once daily in the evening compared to 25 mg thrice daily. Urol Int (2010) 0.81

Retrospective study on stage B prostate cancer in the Hokuriku District, Japan. Int J Urol (2004) 0.81

Enhancement of artificial promoter activity by ultrasound-induced oxidative stress. Ultrason Sonochem (2008) 0.80

Usefulness of single photon emission computed tomography imaging in the detection of lumbar vertebral metastases from prostate cancer. Int J Urol (2008) 0.80

Rapidly progressing renal cell carcinoma associated with Xp11.2 translocations: a case report. J Med Case Rep (2012) 0.80

Differential expression of integrin subunits in DU-145/AR prostate cancer cells. Oncol Rep (2004) 0.80

Sperm with large nuclear vacuoles and semen quality in the evaluation of male infertility. Syst Biol Reprod Med (2012) 0.80

Laparoscopic management of urachal mucinous borderline tumor associated with pseudomyxoma peritonei. Surg Laparosc Endosc Percutan Tech (2011) 0.80

Serum interleukin-11 in patients with benign prostatic hyperplasia and prostate cancer. Int Urol Nephrol (2005) 0.79

Selective renal parenchymal clamping in retroperitoneal partial nephrectomy. J Laparoendosc Adv Surg Tech A (2012) 0.79

A case of renal pelvic tumor visualized by 18F-FDG-PET imaging. Ann Nucl Med (2004) 0.79

[The efficacy of portable 3-dimensional ultrasound scanning device (Bladder Scan BVI6100) for measurement of residual urine volume--comparison with transabdominal ultrasound estimation]. Hinyokika Kiyo (2008) 0.79

Cell proliferation, apoptosis and prognosis in patients with metastatic prostate cancer. Anticancer Res (2003) 0.79

Regulation of gene expression in human prostate cancer cells with artificially constructed promoters that are activated in response to ultrasound stimulation. Ultrason Sonochem (2012) 0.79

Parathyroid hormone related protein producing penile cancer. J Urol (2002) 0.79

Importance of axial penile rigidity in objective evaluation of erection quality in patients with erectile dysfunction--comparison with radial rigidity. Urol Int (2010) 0.78

Laparoscopic ureterolysis for idiopathic retroperitoneal fibrosis. Int J Urol (2005) 0.78

Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells. Oncol Rep (2005) 0.78

Add-on anticholinergic therapy for residual nocturia in patients with lower urinary tract symptoms receiving α1-blocker treatment: a multi-centre, prospective, randomised study. World J Urol (2014) 0.78

Percutaneous endopyelotomy for ureteropelvic junction obstruction. Int Urol Nephrol (2003) 0.77

Expression of tissue factor is associated with clinical features and angiogenesis in prostate cancer. Anticancer Res (2003) 0.77

Regulation of gene expression in retrovirus vectors by X-ray and proton beam radiation with artificially constructed promoters. J Gene Med (2012) 0.77

Early quality of life outcomes in patients with prostate cancer managed by high-dose-rate brachytherapy as monotherapy. Int J Urol (2012) 0.77

The effect of eicosapentaenoic acid on prostate-specific antigen. In Vivo (2006) 0.77

Prognostic significance of serum soluble Fas level and its change during regression and progression of advanced prostate cancer. Endocr J (2003) 0.77

Laparoscopic radical nephrectomy under near real-time three-dimensional surgical navigation with C-arm cone beam computed tomography. Surg Innov (2012) 0.76

Serum hepatocyte growth factor activator inhibitor type I (HAI-I) and type 2 (HAI-2) in prostate cancer. Prostate (2006) 0.76

Low serum testosterone level predicts worse response to endocrine therapy in Japanese patients with metastatic prostate cancer. Endocr J (2002) 0.76

Small cell carcinoma of the prostate after high-dose-rate brachytherapy for low-risk prostatic adenocarcinoma. Oncol Lett (2012) 0.76

Effects of eicosapentaenoic acid on biochemical failure after radical prostatectomy for prostate cancer. In Vivo (2010) 0.76

Longitudinal incision of the umbilicus for laparoendoscopic single site adrenalectomy: a particular intraumbilical technique. Surg Laparosc Endosc Percutan Tech (2010) 0.76

Analysis of inter-examination differences in sperm nuclear vacuoles among male patients with infertility. Syst Biol Reprod Med (2014) 0.76

Preoperative parameters to predict tumor volume in Japanese patients with nonpalpable prostate cancer. Int J Clin Oncol (2002) 0.76

[Bone and Men's Health. Late-onset hypogonadism in males and male menopause (andropause)]. Clin Calcium (2010) 0.76

Telomerase activity in bladder cancer tissue. Exp Ther Med (2010) 0.75

Development of a therapeutically important radiation induced promoter. Bioengineered (2012) 0.75

Differential effect of chromogranin A fragments on invasion and growth of prostate cancer cells in vitro. Urology (2003) 0.75

Hand-assisted laparoscopic radical cystoprostatectomy and urethrectomy with ileal conduit construction. Int Urol Nephrol (2007) 0.75

[Treatment of traditional Chinese medicine for idiopathic male infertility]. Hinyokika Kiyo (2004) 0.75

Multiple organ retraction during urological laparoscopic surgery. J Laparoendosc Adv Surg Tech A (2013) 0.75

Factors influencing patient satisfaction with antimuscarinic treatment of overactive bladder syndrome: results of a real-life clinical study. Int J Urol (2013) 0.75

Comparative study between audiovisualsexual stimulation test and nocturnal penile tumescence test using RigiScan Plus in the evaluation of erectile dysfunction. Urol Int (2004) 0.75